Semaglutide
Reset your appetite, transform your health
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes and later approved for chronic weight management. It works with your body's own appetite-regulating hormones to help you feel full sooner, stay full longer, and reduce food noise. Most patients take it as a once-weekly subcutaneous injection, gradually titrating up over several months. Compounded semaglutide is prescribed off-label for patients who qualify and is used alongside lifestyle changes for the most durable results.
Common reasons patients ask about semaglutide:
Data
Semaglutide has been studied in tens of thousands of patients across the STEP trials (weight management), SUSTAIN trials (type 2 diabetes), and the SELECT cardiovascular outcomes trial. Across these programs, semaglutide has consistently shown clinically meaningful weight loss, improved glycemic control, and — in patients with established cardiovascular disease — a reduction in major adverse cardiovascular events.
~15%
Average body weight reduction at 68 weeks on semaglutide 2.4 mg in STEP 1
20%
Relative reduction in major cardiovascular events in SELECT (patients with established CVD and overweight/obesity)
68 wks
Pivotal STEP 1 trial duration showing sustained weight loss vs. placebo
How it works
Semaglutide mimics GLP-1, a natural hormone that helps regulate appetite, insulin release, and the speed at which your stomach empties. By activating GLP-1 receptors in the brain and gut, it shifts the signals that drive hunger and satiety.
Signals fullness sooner
Activates receptors in the brain that govern appetite, so meals feel satisfying with smaller portions.
Slows gastric emptying
Food stays in the stomach longer, which extends the feeling of fullness between meals.
Supports blood sugar balance
Stimulates insulin release when glucose is high and reduces glucagon, helping stabilize energy throughout the day.
Eligibility
Generally a good fit for
Not appropriate for
A starting point your provider considers alongside your full health profile.
BMI is a screening tool, not a diagnosis. Your provider will review your full health profile during the intake to determine eligibility.
Your BMI
—
Journey
Weeks 1–4
Weeks 5–12
Months 3+
Ongoing
Side effects
Most side effects from semaglutide are gastrointestinal and tend to be mildest at lower doses or when titration is paced slowly. Serious risks are uncommon but important to recognize early.
Common
Less common but serious
If you have questions about whether semaglutide is right for you, your PreventiveMD provider will review your full health history once you get started.
Dosing
Typically titrated from 0.25 mg weekly to a target dose of up to 2.4 mg weekly over roughly 16 weeks, with dose increases every four weeks as tolerated. Specific dose is set by your provider based on goals and tolerance.
How to inject
Seek emergency care immediately if you experience difficulty breathing or swallowing, swelling of the face, lips, tongue, or throat, hives or a widespread rash, dizziness or fainting, or a rapid heartbeat. These can be signs of a serious allergic reaction.
Pricing
Loading pricing…
FAQs
Most people notice reduced appetite within the first two to four weeks. Visible weight loss often begins by week 4–8 and continues steadily through month 6 or beyond. Results vary based on your starting point, dose, and lifestyle.
Semaglutide treats the biology of appetite while you take it. When patients stop without a maintenance plan, some regain is common — which is why we work with you on lifestyle habits and a long-term plan.
Yes. Your provider will review baseline labs (commonly metabolic panel, A1C, lipids, and others as indicated) to confirm semaglutide is appropriate and to track progress.
If it has been fewer than 5 days, take the missed dose as soon as you remember. If more than 5 days have passed, skip it and resume your normal schedule. Never double up.
Alcohol is not directly contraindicated, but it can worsen nausea, dehydration, and low blood sugar — and it stalls weight loss. Most patients find they tolerate much less than they used to.
Our content is reviewed by our medical team and draws from peer-reviewed clinical research, FDA prescribing information, and recognized clinical guidelines. The primary sources cited on this page:
[TODO: Authors, journal, year (DOI when available)]
[TODO: Authors, journal, year (DOI when available)]
How to get started
Currently, we are not yet available in Alaska, Kentucky, Louisiana, Mississippi, New Jersey, New Mexico, Rhode Island, and West Virginia. Get notified once we are.
Complete a 5-minute questionnaire
Choose your protocols
Self-pay checkout
Your provider prescribes if it’s the right fit
By starting, you agree to our Terms of Use and acknowledge our Privacy Policy.